|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Gain on asset sale | |||||
| Adjustments to reconcile net loss to net cash used in operating activities: | |||||
| Depreciation and amortization expense | |||||
| Non-cash asset impairment charges | |||||
| Stock-based compensation expense | |||||
| Loss on sale of property and equipment | |||||
| Non-cash interest expense | |||||
| Non-cash income tax expense | |||||
| (Gain)/loss on impairment of leasehold improvements | |||||
| (Gain)/loss on extinguishment of operating lease | |||||
| Loss on issuance of SAFEs | |||||
| Non-cash lease expense | |||||
| Reduction in the carrying amount of the operating right-of-use assets | |||||
| Change in fair value of SAFE liabilities | |||||
| Change in operating assets and liabilities: | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Other non-current assets | |||||
| Accounts payable | |||||
| Current and non-current operating lease liabilities | |||||
| Accrued expenses and other current liabilities | |||||
| Operating lease liabilities | |||||
| Other non-current liabilities | |||||
| Net cash used in operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from asset sale, net | |||||
| Proceeds from the sale of property, plant, and equipment | |||||
| Purchase of property and equipment | |||||
| Proceeds from the sale of property and equipment | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Repayment of note payable, including end of term charge | |||||
| Proceeds from the issuance of SAFEs | |||||
| Cash acquired in connection with the Merger, net of transaction costs of $9,300 | |||||
| Proceeds from the private placement, net of offering costs of $11,928 | |||||
| Proceeds from the Subscription Agreement, net of offering costs of $2,000 | |||||
| Cash acquired in connection with the Merger, net of transaction costs of $7,412 | |||||
| Proceeds from exercise of stock options | |||||
| Proceeds from issuance of common stock under 2018 employee stock purchase plan | |||||
| Total proceeds from issuance of common stock under 2018 employee stock purchase plan | |||||
| Payments for employee taxes related to net share settlement of equity awards | |||||
| Payment of deferred offering costs | |||||
| Repayment of finance lease obligations | |||||
| Net cash provided by financing activities | |||||
| Effect of exchange rate changes on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents and restricted cash | |||||
| Cash and cash equivalents and restricted cash as of beginning of period | |||||
| Cash and cash equivalents and restricted cash as of end of period | |||||
| Supplemental disclosure of non-cash financing activities: | |||||
| Right of use asset obtained in exchange for operating lease liabilities | |||||
| Conversion of SAFEs to Common Stock | |||||
| Supplemental disclosure of cash flow information: | |||||
| Cash paid for interest | |||||
| Deferred offering costs included in accrued expenses and other liabilities | |||||
| Right-of-use assets obtained in exchange for new operating lease liabilities | |||||
| Conversion of SAFEs to Common Stock | |||||
| Conversion of Convertible Preferred Stock to Common Stock | |||||
| Purchase of equipment through finance leases | |||||
| Merger transaction costs included in accounts payable and accrued expenses | |||||
| Components of cash, cash equivalents and restricted cash: | |||||
| Cash and cash equivalents | |||||
| Restricted cash | |||||
Loading...